Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06008353
Status:
RECRUITING
Last Update Posted:
2023-10-11
First Post:
2023-03-07
Brief Title:
A Real-World Assessment of the Demographic Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in ES-SCLC in Brazil
Sponsor:
Latin American Cooperative Oncology Group
Organization:
Latin American Cooperative Oncology Group
Organization Data
Organization:
Latin American Cooperative Oncology Group
Class:
OTHER
Study ID:
LACOG 0322
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Latin American Cooperative Oncology Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |